UnitedHealth Group Inc (UNH) stock
Close on Oct 30, 2026Market cap $365.29BP/E 26.2Yield 2.15%
Earnings
UnitedHealth's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of UnitedHealth's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Jan 26, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 13, 2026before the open | $112.70B | -0.4% | $4.56 | $4.69 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 16, 2026before the open | $112.00B | – | $6.04 | $6.38 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 21, 2026before the open | $111.70B | +1.9% | $6.90 | $7.23 | Release |
| Q4 FY2025ended Dec 31, 2025 | Jan 27, 2026before the open | $113.20B | +12.3% | $0.01 | $2.11 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 28, 2025before the open | $113.20B | +12.3% | $2.59 | $2.92 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 29, 2025before the open | – | – | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 17, 2025before the open | $109.60B | +9.8% | $6.85 | $7.20 | Release |
| Q4 FY2024ended Dec 31, 2024 | Jan 16, 2025before the open | $100.81B | +6.8% | $5.98 | $6.81 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 15, 2024before the open | $100.80B | +9.1% | $6.51 | $7.15 | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 16, 2024before the open | $98.90B | +6.5% | $4.54 | $6.80 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 16, 2024before the open | $99.80B | +8.6% | -$1.53 | $6.91 | Release |
| Q4 FY2023ended Dec 31, 2023 | Jan 12, 2024before the open | $94.40B | +14.0% | $5.83 | $6.16 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 13, 2023before the open | $92.40B | +14.2% | $6.24 | $6.56 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 14, 2023before the open | $92.90B | +15.7% | $5.82 | $6.14 | Release |
| Q1 FY2023ended Mar 31, 2023 | Apr 14, 2023before the open | $91.90B | +14.7% | $5.95 | $6.26 | Release |
| Q4 FY2022ended Dec 31, 2022 | Jan 13, 2023before the open | $82.80B | +12.3% | $5.03 | $5.34 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 14, 2022before the open | $80.90B | +11.9% | $5.55 | $5.79 | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 15, 2022before the open | $80.30B | – | $5.34 | $5.57 | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 14, 2022before the open | $80.10B | – | $5.27 | $5.49 | Release |
| Q4 FY2021ended Dec 31, 2021 | Jan 19, 2022before the open | $73.70B | – | $4.26 | $4.48 | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 14, 2021before the open | $72.30B | – | $4.28 | $4.52 | Release |
| Q2 FY2021ended Jun 30, 2021 | Jul 15, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | Apr 15, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Jan 20, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 14, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
UnitedHealth's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Revenues | FY2026 | $439.00B | – | New | Jan 27, 2026 |
| Optum Insight Adjusted Operating Earningsnon-GAAP | FY2026 | $4.75B | – | Raised | Jul 16, 2026 |
| UnitedHealthcare Operating EarningsGAAP | FY2026 | $12.00B | $24.00B | Lowered | Jul 16, 2026 |
| Operating Margin | FY2026 | 5.5% | – | New | Jan 27, 2026 |
| Diluted earnings per shareGAAP | FY2026 | $19.50 | – | New | Oct 13, 2026 |
| Diluted Net Earnings per ShareGAAP | FY2026 | $18.45 – $18.95 | $17.35 | Raised | Jul 16, 2026 |
| Adjusted Earnings per Sharenon-GAAP | FY2026 | $19.50 – $20.00 | $18.25 | Raised | Jul 16, 2026 |
| adjusted net earningsnon-GAAP | FY2026 | $20.50 | – | New | Oct 13, 2026 |
| Capital Expenditures | FY2026 | $3.80B | – | New | Jan 27, 2026 |
| Cash Flows from Operations | FY2026 | $24.00B | – | New | Jul 16, 2026 |
| Medical Care Ratio | FY2026 | 88.1% | – | New | Jul 16, 2026 |
| Net Earnings to UNH ShareholdersGAAP | FY2026 | $16.75B | – | New | Jul 16, 2026 |
| Share Repurchase | FY2026 | $5.00B | – | Lowered | Jul 16, 2026 |
| Tax Rate | FY2026 | 18.5% | – | Lowered | Jul 16, 2026 |
Guidance history
Every forecast UnitedHealth put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 13, 2026 | adjusted net earnings | FY2026 | $20.50 | New |
| Oct 13, 2026 | Diluted earnings per share | FY2026 | $19.50 | New |
| Jul 16, 2026 | Adjusted Earnings per Share | FY2026 | $19.50 – $20.00 | Raised |
| Jul 16, 2026 | Diluted Net Earnings per Share | FY2026 | $18.45 – $18.95 | Raised |
| Jul 16, 2026 | Optum Insight Adjusted Operating Earnings | FY2026 | $4.75B | Raised |
| Jul 16, 2026 | Optum Health Adjusted Operating Earnings | FY2026 | $2.22B | Lowered |
| Jul 16, 2026 | UnitedHealthcare Adjusted Operating Earnings | FY2026 | $12.00B | New |
| Jul 16, 2026 | UnitedHealthcare Operating Earnings | FY2026 | $12.00B | Lowered |
| Jul 16, 2026 | Optum Health Operating Earnings | FY2026 | $2.28B | Lowered |
| Jul 16, 2026 | Optum Insight Operating Earnings | FY2026 | $4.93B | Raised |
| Jul 16, 2026 | Optum Rx Operating Earnings | FY2026 | $6.25B | Raised |
| Jul 16, 2026 | Optum Operating Earnings | FY2026 | $13.45B | Raised |
| Jul 16, 2026 | UnitedHealth Group Operating Earnings | FY2026 | $25.45B | Raised |
| Jul 16, 2026 | Optum Adjusted Operating Earnings | FY2026 | $13.22B | Raised |
| Jul 16, 2026 | UnitedHealth Group Adjusted Operating Earnings | FY2026 | $25.22B | Raised |
| Jul 16, 2026 | Optum Rx Adjusted Operating Earnings | FY2026 | $6.25B | Raised |
| Jul 16, 2026 | Tax Rate | FY2026 | 18.5% | Lowered |
| Jul 16, 2026 | Medical Care Ratio | FY2026 | 88.1% | New |
| Jul 16, 2026 | Cash Flows from Operations | FY2026 | $24.00B | New |
| Jul 16, 2026 | Share Repurchase | FY2026 | $5.00B | Lowered |
| Jul 16, 2026 | Net Earnings to UNH Shareholders | FY2026 | $16.75B | New |
| Apr 21, 2026 | adjusted net earnings | FY2026 | $18.25 | Raised |
| Apr 21, 2026 | Earnings | FY2026 | $17.35 | Raised |
| Jan 27, 2026 | Capital Expenditures | FY2026 | $3.80B | New |
| Jan 27, 2026 | Adjusted Earnings | FY2026 | $17.75 | New |
| Jan 27, 2026 | Earnings Outlook | FY2026 | $17.10 | New |
| Jan 27, 2026 | Earnings from Operations | FY2026 | $24.00B | New |
| Jan 27, 2026 | Operating Margin | FY2026 | 5.5% | New |
| Jan 27, 2026 | Revenues | FY2026 | $439.00B | New |
| Oct 28, 2025 | adjusted net earnings | FY2025 | $16.25 | New |
| Oct 28, 2025 | net earnings | FY2025 | $14.90 | New |
| Apr 17, 2025 | adjusted earnings | FY2025 | $26.00 – $26.50 | Lowered |
| Apr 17, 2025 | net earnings | FY2025 | $24.65 – $25.15 | Lowered |
| Jan 16, 2025 | adjusted net earnings per share | FY2025 | $29.50 – $30.00 | New |
| Jan 16, 2025 | net earnings per share | FY2025 | $28.15 – $28.65 | New |
| Jan 16, 2025 | cash flow from operations | FY2025 | $32.00B – $33.00B | New |
| Jan 16, 2025 | revenues | FY2025 | $450.00B – $455.00B | New |
| Oct 15, 2024 | adjusted net earnings outlook | FY2024 | $27.50 – $27.75 | Lowered |
| Oct 15, 2024 | net earnings outlook | FY2024 | $15.50 – $15.75 | Lowered |
| Jul 16, 2024 | adjusted net earnings outlook | FY2024 | $27.50 – $28.00 | Reaffirmed |
| Jul 16, 2024 | net earnings outlook | FY2024 | $15.95 – $16.40 | Lowered |
| Jul 16, 2024 | Medical care ratio | FY2024 | 84.3% | New |
| Jul 16, 2024 | Adjusted medical care ratio | FY2024 | 84% | New |
| Apr 16, 2024 | adjusted net earnings | FY2024 | $27.50 – $28.00 | New |
| Apr 16, 2024 | net earnings | FY2024 | $17.60 – $18.20 | New |
| Oct 13, 2023 | adjusted net earnings | FY2023 | $24.85 – $25.00 | Raised |
| Oct 13, 2023 | net earnings | FY2023 | $23.60 – $23.75 | Raised |
| Jul 14, 2023 | adjusted net earnings | FY2023 | $24.70 – $25.00 | Raised |
| Jul 14, 2023 | net earnings | FY2023 | $23.45 – $23.75 | Raised |
| Apr 14, 2023 | adjusted net earnings | FY2023 | $24.50 – $25.00 | Raised |
| Apr 14, 2023 | net earnings | FY2023 | $23.25 – $23.75 | Raised |
| Jan 13, 2023 | adjusted net earnings per share | FY2023 | $24.40 – $24.90 | New |
| Jan 13, 2023 | net earnings per share | FY2023 | $23.15 – $23.65 | New |
| Jan 13, 2023 | cash flows from operations | FY2023 | $27.00B – $28.00B | New |
| Jan 13, 2023 | revenues | FY2023 | $357.00B – $360.00B | New |
| Oct 14, 2022 | adjusted net earnings | FY2022 | $21.85 – $22.05 | Raised |
| Oct 14, 2022 | net earnings | FY2022 | $20.85 – $21.05 | Raised |
| Jul 15, 2022 | adjusted net earnings | FY2022 | $21.40 – $21.90 | Raised |
| Jul 15, 2022 | net earnings | FY2022 | $20.45 – $20.95 | Raised |
| Apr 14, 2022 | adjusted net earnings | FY2022 | $21.20 – $21.70 | Raised |
| Apr 14, 2022 | net earnings | FY2022 | $20.30 – $20.80 | Raised |
| Jan 19, 2022 | adjusted net earnings | FY2022 | $21.10 – $21.60 | New |
| Jan 19, 2022 | net earnings | FY2022 | $20.20 – $20.70 | New |
| Jan 19, 2022 | cash flows from operations | FY2022 | $23.00B – $24.00B | New |
| Jan 19, 2022 | revenues | FY2022 | $317.00B – $320.00B | New |
| Oct 14, 2021 | adjusted earnings | FY2021 | $18.65 – $18.90 | New |
| Oct 14, 2021 | net earnings | FY2021 | $17.70 – $17.95 | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases UnitedHealth filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- News
- Update